Big promises, hard work: What 2026 will demand from pharma
Eloise McLennan looks at a set of signals areas where pressure is building and 2026 looks set to demand more clarity, discipline, and follow-through.
Newsletters and Deep Dive digital magazine
Eloise McLennan looks at a set of signals areas where pressure is building and 2026 looks set to demand more clarity, discipline, and follow-through.
An emerging consensus across sponsors, investigators, and regulators is that agility must become a defining attribute of CRO performance.
Dermot Kenny, who leads STEM and Research Partnership at Inizio Advisory, shares his journey from bench scientist to CEO in a new 12 Questions With.
Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.
At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...
Editor's Picks
Newsletters and Deep Dive
digital magazine